The Flowr Corporation Stock Toronto S.E.
Equities
FLWR.H
CA34354X1087
Pharmaceuticals
Sales 2020 | 7.51 10.27 | Sales 2021 | 12.35 16.88 | Capitalization | 22.37M 30.58M |
---|---|---|---|---|---|
Net income 2020 | -126M -172M | Net income 2021 | -85M -116M | EV / Sales 2020 | 16,546,858 x |
Net Debt 2020 | 29.2M 39.92M | Net Debt 2021 | 17.1M 23.37M | EV / Sales 2021 | 3,196,178 x |
P/E ratio 2020 |
-0.35
x | P/E ratio 2021 |
-0.24
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 65.85% |
1st Jan change | Capi. | |
---|---|---|
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |